Prescription drug · NDA
Striverdi Respimat (olodaterol respimat inhalation spray) NDC 0597-0192
Olodaterol hydrochloride 2.5 ug/1 · Spray, Metered · Respiratory (Inhalation) · Boehringer Ingelheim Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0597-0192-61 | 00597019261 | 1 CARTRIDGE in 1 CARTON (0597-0192-61) / 60 SPRAY, METERED in 1 CARTRIDGEMarketed from Aug 1, 2014 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Striverdi Respimat
- Generic name (nonproprietary)
- olodaterol respimat inhalation spray
- Active ingredients
- Olodaterol hydrochloride — 2.5 ug/1
- Dosage form
- Spray, Metered
- Route
- Respiratory (Inhalation)
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 203108
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic beta2-Agonists (Mechanism)
- Identifiers
- Product ID 0597-0192_376b43be-46b2-49d7-bc0f-a6408571efeaSPL ID 376b43be-46b2-49d7-bc0f-a6408571efeaSPL set ID 5d9a5433-857e-44ea-b3d6-2a400ca0cef5RxCUI 1546082, 1546083UNII 65R445W3V9
- Pharmacologic class
- beta2-Adrenergic Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N400597019261followed by a unit qualifier and the quantityPackage 00597-0192-61. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
STRIVERDI RESPIMAT Inhalation Spray is a long-acting beta 2 -adrenergic agonist (LABA) indicated for: The long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. ( 1.1 ) Important limitations: STRIVERDI RESPIMAT is NOT indicated to treat acute deterioration of COPD. ( 1.2 ) STRIVERDI RESPIMAT is NOT indicated to treat asthma. ( 1.2 ) 1.1 Maintenance Treatment of COPD STRIVERDI RESPIMAT is a long-acting beta 2 -agonist indicated for long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary…
Excerpt only. Read the full label for complete information.